BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 19996864)

  • 21. Twin pregnancy and the risk of preeclampsia: bigger placenta or relative ischemia?
    Bdolah Y; Lam C; Rajakumar A; Shivalingappa V; Mutter W; Sachs BP; Lim KH; Bdolah-Abram T; Epstein FH; Karumanchi SA
    Am J Obstet Gynecol; 2008 Apr; 198(4):428.e1-6. PubMed ID: 18191808
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypoxia-induced increase in soluble Flt-1 production correlates with enhanced oxidative stress in trophoblast cells from the human placenta.
    Li H; Gu B; Zhang Y; Lewis DF; Wang Y
    Placenta; 2005; 26(2-3):210-7. PubMed ID: 15708122
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Placental-Specific sFLT-1 e15a Protein Is Increased in Preeclampsia, Antagonizes Vascular Endothelial Growth Factor Signaling, and Has Antiangiogenic Activity.
    Palmer KR; Kaitu'u-Lino TJ; Hastie R; Hannan NJ; Ye L; Binder N; Cannon P; Tuohey L; Johns TG; Shub A; Tong S
    Hypertension; 2015 Dec; 66(6):1251-9. PubMed ID: 26416849
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia.
    Ahmad S; Ahmed A
    Circ Res; 2004 Oct; 95(9):884-91. PubMed ID: 15472115
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating angiogenic factors and their association with birth outcomes in preeclampsia.
    Kulkarni AV; Mehendale SS; Yadav HR; Kilari AS; Taralekar VS; Joshi SR
    Hypertens Res; 2010 Jun; 33(6):561-7. PubMed ID: 20224572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiogenic imbalance and diminished matrix metalloproteinase-2 and -9 underlie regional decreases in uteroplacental vascularization and feto-placental growth in hypertensive pregnancy.
    Dias-Junior CA; Chen J; Cui N; Chiang CL; Zhu M; Ren Z; Possomato-Vieira JS; Khalil RA
    Biochem Pharmacol; 2017 Dec; 146():101-116. PubMed ID: 28912068
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Soluble Fms-like tyrosine kinase associated with preeclampsia in pregnancy in systemic lupus erythematosus.
    Qazi U; Lam C; Karumanchi SA; Petri M
    J Rheumatol; 2008 Apr; 35(4):631-4. PubMed ID: 18278839
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Angiogenic growth factors in maternal and fetal serum in pregnancies complicated by intrauterine growth restriction.
    Wallner W; Sengenberger R; Strick R; Strissel PL; Meurer B; Beckmann MW; Schlembach D
    Clin Sci (Lond); 2007 Jan; 112(1):51-7. PubMed ID: 16928195
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alterations in placental growth factor levels before and after the onset of preeclampsia are more pronounced in women with early onset severe preeclampsia.
    Ohkuchi A; Hirashima C; Matsubara S; Suzuki H; Takahashi K; Arai F; Watanabe T; Kario K; Suzuki M
    Hypertens Res; 2007 Feb; 30(2):151-9. PubMed ID: 17460385
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thrombin enhances soluble Fms-like tyrosine kinase 1 expression in trophoblasts; possible involvement in the pathogenesis of preeclampsia.
    Zhao Y; Koga K; Osuga Y; Nagai M; Izumi G; Takamura M; Harada M; Hirota Y; Yoshino O; Taketani Y
    Fertil Steril; 2012 Oct; 98(4):917-21. PubMed ID: 22819145
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypoxia down-regulates placenta growth factor, whereas fetal growth restriction up-regulates placenta growth factor expression: molecular evidence for "placental hyperoxia" in intrauterine growth restriction.
    Khaliq A; Dunk C; Jiang J; Shams M; Li XF; Acevedo C; Weich H; Whittle M; Ahmed A
    Lab Invest; 1999 Feb; 79(2):151-70. PubMed ID: 10068204
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Altered angiogenesis in preeclampsia: evaluation of a new test system for measuring placental growth factor.
    Schmidt M; Dogan C; Birdir C; Callies R; Kuhn U; Gellhaus A; Janetzko A; Kimmig R; Kasimir-Bauer S
    Clin Chem Lab Med; 2007; 45(11):1504-10. PubMed ID: 17970705
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thrombin regulates soluble fms-like tyrosine kinase-1 (sFlt-1) expression in first trimester decidua: implications for preeclampsia.
    Lockwood CJ; Toti P; Arcuri F; Norwitz E; Funai EF; Huang ST; Buchwalder LF; Krikun G; Schatz F
    Am J Pathol; 2007 Apr; 170(4):1398-405. PubMed ID: 17392178
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia.
    Maynard SE; Min JY; Merchan J; Lim KH; Li J; Mondal S; Libermann TA; Morgan JP; Sellke FW; Stillman IE; Epstein FH; Sukhatme VP; Karumanchi SA
    J Clin Invest; 2003 Mar; 111(5):649-58. PubMed ID: 12618519
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypoxic trophoblast-derived sFlt-1 may contribute to endothelial dysfunction: implication for the mechanism of trophoblast-endothelial dysfunction in preeclampsia.
    Zhou Q; Qiao FY; Zhao C; Liu HY
    Cell Biol Int; 2011 Jan; 35(1):61-6. PubMed ID: 20828367
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Atorvastatin increases plasma soluble Fms-like tyrosine kinase-1 and decreases vascular endothelial growth factor and placental growth factor in association with improvement of ventricular function in acute myocardial infarction.
    Kodama Y; Kitta Y; Nakamura T; Takano H; Umetani K; Fujioka D; Saito Y; Kawabata K; Obata JE; Mende A; Kobayashi T; Kugiyama K
    J Am Coll Cardiol; 2006 Jul; 48(1):43-50. PubMed ID: 16814647
    [TBL] [Abstract][Full Text] [Related]  

  • 37. VEGF (Vascular Endothelial Growth Factor) Functionalized Magnetic Beads in a Microfluidic Device to Improve the Angiogenic Balance in Preeclampsia.
    Trapiella-Alfonso L; Alexandre L; Fraichard C; Pons K; Dumas S; Huart L; Gaucher JF; Hebert-Schuster M; Guibourdenche J; Fournier T; Vidal M; Broutin I; Lecomte-Raclet L; Malaquin L; Descroix S; Tsatsaris V; Gagey-Eilstein N; Lecarpentier E
    Hypertension; 2019 Jul; 74(1):145-153. PubMed ID: 31079531
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Placental angiogenesis markers sFlt-1 and PlGF: response to cigarette smoke.
    Mehendale R; Hibbard J; Fazleabas A; Leach R
    Am J Obstet Gynecol; 2007 Oct; 197(4):363.e1-5. PubMed ID: 17904960
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Angiogenesis-related biomarkers (sFlt-1/PlGF) in placental mesenchymal dysplasia.
    Herraiz I; Simón E; Toldos Ó; Rodríguez Y; Gómez-Arriaga PI; Galindo A
    J Matern Fetal Neonatal Med; 2017 Apr; 30(8):958-961. PubMed ID: 27240524
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lymphokine-activated killer cells induced from decidual lymphocytes reduce the angiogenic activity of trophoblasts by enhancing the release of soluble fms-like tyrosine kinase-1 from trophoblasts: an implication for the pathophysiology of preeclampsia.
    Matsubara K; Nagamatsu T; Fujii T; Kozuma S; Taketani Y
    J Reprod Immunol; 2005 Dec; 68(1-2):27-37. PubMed ID: 16229897
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.